ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,949, issued on Oct. 7, was assigned to Novartis AG (Basel, Switzerland).
"Sustained release delivery systems comprising traceless linkers" was invented by Christopher M. Adams (Arlington, Mass.), Myriam April (Cambridge, Mass.), Tanzina Fazal (Burlington, Mass.), Cornelia Jutta Forster (Pelham, N.H.), Edward Charles Hall (Boston) and Cameron Chuck-munn Lee (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery re...